Q1 2018 Holdings
Filed 2018-05-04 | 11 holdings | $175.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arsanis, Inc. | Common Stock | 042873109 | $42.8K | 1,868,957 | 24.4% |
| Cardlytics, Inc.(CDLX) | Common Stock | 14161W105 | $38.6K | 2,636,262 | 22.0% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $29.4K | 1,857,582 | 16.8% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $24.1K | 2,473,186 | 13.8% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $16.4K | 1,606,813 | 9.3% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $12.2K | 1,875,524 | 6.9% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $4.8K | 1,827,992 | 2.8% |
| Trevena, Inc. | Common Stock | 89532E109 | $3.4K | 2,053,540 | 1.9% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $2.1K | 1,968,606 | 1.2% |
| Pulmatrix, Inc. | Common Stock | 74584P103 | $1.4K | 2,796,407 | 0.8% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $273 | 326,243 | 0.2% |